izpis_h1_title_alt

Synthesis of 3-amino-4-substituted monocyclic ß-lactams—important structural motifs in medicinal chemistry
ID Grabrijan, Katarina (Avtor), ID Strašek Benedik, Nika (Avtor), ID Gobec, Stanislav (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (3,51 MB)
MD5: B8E754148E25936B066BFC1AC7DD6BE7
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1422-0067/23/1/360 Povezava se odpre v novem oknu

Izvleček
Monocyclic ß-lactams (azetidin-2-ones) exhibit a wide range of biological activities, the most important of which are antibacterial, anticancer, and cholesterol absorption inhibitory activities. The synthesis of decorated monocyclic ß-lactams is challenging because their ring is highly constrained and consequently reactive, which is also an important determinant of their biological activity. We present the optimized synthesis of orthogonally protected 3-amino-4-substituted monocyclic ß-lactams. Among several possible synthetic approaches, Staudinger cycloaddition proved to be the most promising method for initial ring formation, yielding monocyclic ß-lactams with different substituents at the C-4 position, a phthalimido-protected 3-amino group, and a (dimethoxy)benzyl protected ring nitrogen. Challenging deprotection methods were then investigated. Oxidative cleavage with cerium ammonium nitrate and ammonia-free Birch reduction was found to be most effective for selective removal of ring nitrogen protection. Hydrazine hydrate was used for deprotection of the phthalimido group, and the procedure had to be modified by the addition of HCl in the case of aromatic substituents at the C-4 position. The presented methods and the synthesized 3-amino-4-substituted monocyclic ß-lactam derivatives are an important step toward new ß-lactams with potential pharmacological activities.

Jezik:Angleški jezik
Ključne besede:monocyclic ß-lactam, Staudinger [2+2] cyclocondensation, cerium ammonium nitrate, hydrazine hydrate, 3-amino-4-substituted azetidin-2-one, inhibitory activities
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2022
Št. strani:26 str.
Številčenje:Vol. 23, iss. 1, art. 360
PID:20.500.12556/RUL-136778 Povezava se odpre v novem oknu
UDK:615.4:54
ISSN pri članku:1422-0067
DOI:10.3390/ijms23010360 Povezava se odpre v novem oknu
COBISS.SI-ID:92152323 Povezava se odpre v novem oknu
Datum objave v RUL:20.05.2022
Število ogledov:629
Število prenosov:120
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:International journal of molecular sciences
Skrajšan naslov:Int. j. mol. sci.
Založnik:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:01.01.2022

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:monociklični ß-laktam, Staudingerjeva [2+2] ciklokondenzacija, cerijev amonijev nitrat, hidrazin hidrat, 3-amino-4-substituiran azetidin-2-on, inhibitorna aktivnost, farmacevtska kemija

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Program financ.:Young researchers

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0208
Naslov:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj